Ocugen (OCGN) Times Interest Earned (2014 - 2026)
Ocugen's (OCGN) quarterly Times Interest Earned came in at -$0.98 in Q1 2026, up 91.47% YoY from -$0.51 in Q1 2025, and up 92.28% on a QoQ basis from -$12.76 in Q4 2025.
Ocugen (OCGN) Times Interest Earned (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Times Interest Earned data on file, last reported at -$0.98 in Q1 2026.
- Quarterly Times Interest Earned rose 91.47% year-over-year to -$0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.66 (up 87.78% YoY) and the FY2025 annual result came in at -$0.46, down 1.02% from the prior year.
- Times Interest Earned improved to -$0.98 in Q1 2026, from -$12.76 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.1 in Q4 2023 to a low of -$456.97 in Q3 2024.
- A 5-year average of -$32.21 and a median of -$3.74 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 99.97% — and 2024, when it slumped 22361.42%.
- Tracing OCGN's Times Interest Earned over 5 years: stood at -$0.24 in 2022, then jumped by 57.98% to -$0.1 in 2023, then tumbled by 22361.42% to -$23.03 in 2024, then surged by 44.59% to -$12.76 in 2025, then jumped by 92.28% to -$0.98 in 2026.
- The last three Times Interest Earned figures came in at -$0.98 (Q1 2026), -$12.76 (Q4 2025), and -$13.41 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | -1.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60 |
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -12.76 |
| Sep 30, 2025 | -13.41 |
| Jun 30, 2025 | -2.17 |
| Mar 31, 2025 | -11.54 |
| Dec 31, 2024 | -23.03 |
| Sep 30, 2024 | -456.97 |
| Jun 30, 2024 | -2.79 |
| Mar 31, 2024 | -1.97 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -2.80 |
| Jun 30, 2023 | -5.09 |
| Mar 31, 2023 | -3.74 |
| Dec 31, 2022 | -0.24 |
| Sep 30, 2022 | -4.83 |
| Jun 30, 2022 | -3.87 |
| Mar 31, 2022 | -1.32 |
| Dec 31, 2021 | -728.60 |
| Sep 30, 2021 | -0.22 |